Chimeric Therapeutics Limited (ASX:CHM) Reports Q4 Activities
Chimeric Therapeutics (ASX:CHM) advances clinical trials, secures $5M in funding, and appoints Dr Rebecca McQualter as CEO in Q4 report.
Tag: Industry-Specific News
Marquee Resources (ASX:MQR) Releases Q4 2024 Activities Report
Marquee Resources (ASX:MQR) reports significant exploration progress and strong financial updates in its Q4 2024 Activities Report.
Terra Metals Limited (ASX:TM1) Reports High-Grade Drill Results and Expands Dante Project
Terra Metals Limited (ASX:TM1) reports high-grade drill results at Dante Project and secures options for additional tenements, enhancing its mineral portfolio.
Dotz Nano Ltd (ASX:DTZ) Secures First US Commercial Order and A$2M Investment
Dotz Nano Ltd (ASX:DTZ) secures its first US commercial order for DotzShield and receives a further A$2M investment to advance carbon capture technologies.
Accelerate Resources (ASX:AX8) Announces A$1.35M Capital Raising
Accelerate Resources (ASX:AX8) secures A$1.35M to advance its gold strategy and exploration activities.
Australian Pacific Coal Limited (ASX:AQC) Releases Quarterly Activities Report
Australian Pacific Coal Limited (ASX:AQC) reports first commercial coal rail, production ramp-up, and financing achievements in Q4 2024 activities report.
Peninsula Energy Limited (ASX:PEN) Restarts Lance Uranium Production and Appoints New CEO
Peninsula Energy Limited (ASX:PEN) restarts Lance uranium production and appoints a new CEO, strengthening its position as an independent uranium producer.
Opthea Limited (ASX:OPT) Releases Q2 FY25 Activity Report
Opthea Limited (ASX:OPT) releases Q2 FY25 Activity Report, detailing advancements in Phase 3 trials and financial developments including a R&D tax incentive.
EVE Health Group (ASX:EVE) Announces Strategic Developments
EVE Health Group (ASX:EVE) shares updates on its operational achievements and financial performance, focusing on growth and strategic initiatives.
KNeoMedia Limited (ASX: KNM) Provides Quarterly Update
KNeoMedia Limited (ASX: KNM) outlines key financial developments and contract progress in its quarterly update.